←Back to Expert Scholars
Translational Medicine / 转化医学Therapy-Related MDS, Clonal Evolution
Timothy Graubert
MD
🏢Massachusetts General Hospital🌐USA
Chief, Leukemia Center
70
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Timothy Graubert investigates therapy-related MDS and AML, characterizing the clonal evolution from CHIP through frank malignancy following cytotoxic therapy. His laboratory has defined splicing factor mutations as drivers of MDS pathogenesis.
Share:
🧪Research Fields 研究领域
therapy-related MDS
clonal evolution leukemia
splicing factor mutations
SF3B1 mutations
genomic MDS
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Timothy Graubert 的研究动态
Follow Timothy Graubert's research updates
留下邮箱，当我们发布与 Timothy Graubert（Massachusetts General Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment